Vz, the terminal phase volume: Time for its terminal phase?

Journal of Biopharmaceutical Statistics

Volumn 11, Issue 4, 2001, Pages 373-375

  Gobburu, Jogarao V S ^a   Holford, Nicholas H G ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN;

AREA UNDER THE CURVE; BIOAVAILABILITY; COMPARTMENT MODEL; DRUG ELIMINATION; LETTER; PHASE SEPARATION; PRIORITY JOURNAL; SIMULATION; STEADY STATE;

DATA INTERPRETATION, STATISTICAL; HUMANS; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 0035560833     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120006097     Document Type: Letter

References (3)

1. Guidelines for collection and analysis of pharmacokinetic data
2. Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen